598 related articles for article (PubMed ID: 11356068)
21. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
Wang B; Weng J
Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
[TBL] [Abstract][Full Text] [Related]
22. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
23. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
24. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
[TBL] [Abstract][Full Text] [Related]
25. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
26. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
27. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
28. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
Wang X; Li L; Feng K; Bai L; Pei X
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
[TBL] [Abstract][Full Text] [Related]
29. [Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro].
Wang JB; Ge J; Liu BQ; Huang B; Wei YT
Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):212-7. PubMed ID: 16643751
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
31. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
32. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
Huang H; Wang A
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726
[TBL] [Abstract][Full Text] [Related]
33. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
34. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo.
He XL; Guo XJ; Qian GS; He XH; Huang GJ; Chen WZ; Li SP
Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772
[TBL] [Abstract][Full Text] [Related]
35. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
36. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
37. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
38. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
39. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
